| Bovine papillomavirus E5 protein |
The laboratory is interested in determining
the mechanism of action of viral oncogenes, with the belief
that these studies will provide new insight into signal transduction
and the control of cell proliferation. For many years, we have
studied the E5 oncoprotein of bovine papillomavirus (BPV), a
small DNA tumor virus closely related to the human papillomaviruses
that cause a variety of human cancers. The forty-four amino
acid BPV E5 protein is the shortest protein known to cause tumorigenic
transformation of cells . In transformed cells, the E5 protein
exists as a dimeric transmembrane protein with a very hydrophobic
central domain that spans the membranes of the Golgi apparatus
and endoplasmic reticulum (Figure E5.1).
MET-PRO-ASN-LEU-TRP-PHE-LEU-LEU-PHE-LEU-GLY-LEU-
VAL-LEU-ALA-ALA-MET-GLN-LEU-LEU-LEU-LEU-LEU-PHE-
LEU-LEU-LEU-PHE-PHE-LEU-VAL-TYR-TRP- ASP-HIS-PHE-
GLU-CYS-SER-CYS-THR-GLY-LEU-PRO-PHE |
| Figure E5.1 Amino acid sequence of
the BPV E5 protein |
We showed that the E5 protein specifically binds
to and activates the platelet-derived growth factor ß
receptor, a cellular transmembrane receptor tyrosine kinase
that normally transduces signals from PDGF, a soluble ligand.
The E5/PDGF receptor interaction results in growth stimulation
and tumorigenic transformation of cells. These findings demonstrated
that receptor tyrosine kinases can be activated by proteins
that do not resemble their normal ligands. We also showed that
direct interactions involving specific transmembrane and juxtamembrane
amino acids in the E5 protein and the PDGF ß receptor
result in dimerization and trans-phosphorylation of the receptor,
and recruitment of cellular signaling molecules into a signal
transduction complex. Thus, the E5 protein acts as a specific,
intramembrane crosslinker of the PDGF ß receptor (Figure
E5.2). We are conducting genetic and biochemical experiments
to define the structure of this unique complex, in the belief
that it will provide new insight into the assembly of transmembrane
protein complexes in general. Experiments are also underway
to determine whether the same intracellular pathways are mobilized
when the PDGF ß receptor is activated by PDGF, by the
E5 protein, or by activating mutations in the receptor.

Figure E5.2 Schematic model
of PDGF ß receptor activated by PDGF (left) and by the
BPV E5 protein (right). The horizontal lines represent the lipid
bilayer of cell membranes.
|